A menopause interview separates chosen sexual privacy from shame, with clinical context on desire, vaginal comfort and raising concerns in private.
On 2026-10-30, DESIblitz published an interview with psychotherapist and broadcaster Lucy Beresford about the difference between choosing sexual privacy and feeling too ashamed to seek help. The discussion included menopause-related changes in comfort and desire while challenging the assumption that menopause ends a woman’s sexuality.
The idea under scrutiny is a social assumption rather than an established medical consensus: that sexuality becomes irrelevant after menopause or that intimate concerns should remain unspoken. Beresford’s argument is not that women should disclose more about their sex lives. It is that keeping something private should remain a choice rather than a barrier to care.
Existing clinical guidance already recognises menopause-associated genital and sexual symptoms. The MSD Manual describes assessment and several approaches to managing them. The interview’s contribution is to ask whether women feel able to bring those concerns into a consultation in the first place.
The interview’s main points sit alongside established clinical context:
The DESIblitz piece is a reported interview rather than a clinical trial or a new treatment guideline. Its discussion of South Asian women’s experiences also needs careful boundaries.
It describes a 2025 qualitative study of British-born South Asian women aged 18 to 25 in North-West England. Participants discussed sexual agency and the place of culture and religion in their experiences of sexual-health services. Those accounts do not establish how common particular experiences are across South Asian communities. They should not be used to predict the experiences of women over 40.
DESIblitz also reports a separate UK study involving South Asian women aged 18 and over. Participants described limited knowledge of services alongside stigma and shame. Confidentiality concerns were another reported barrier. These accounts are not population-wide estimates or findings specific to menopausal women.
Taken together, this material supports asking about barriers rather than assigning them to a woman because of her background. The useful question is what makes care accessible to her, not what a cultural label supposedly reveals about her private life.
Beresford’s distinction leaves room for a woman to value discretion without having that preference treated as a problem. Someone may not want to discuss sex with friends or relatives. That choice is separate from whether she feels able to mention pain or ask a health question during an appointment.
In Beresford’s account, the concern begins when a person feels there is something wrong with having sexual feelings or needing information. She argues that silence can become costly when it blocks help for pain or other sexual-health concerns. The proposed response is access to a safe conversation rather than an expectation of greater openness everywhere.
That is a useful editorial boundary for discussions of cultural stigma. Privacy does not need correcting. A barrier that leaves a woman unable to raise a concern deserves attention. Neither point requires assumptions about how much she should share or with whom.
The interview brings desire and physical comfort into the same discussion without making them interchangeable. That distinction matters when deciding what a conversation with a clinician is actually about.
A concern about dryness can be named as dryness. Pain during sex can be named as pain. A change in sexual interest can be discussed in its own terms rather than being treated as proof that something is wrong with the whole of a woman’s sexual life.
Beresford’s practical suggestion is to be specific about changes in desire or comfort. That gives the clinical conversation a clearer starting point than the broad statement that sex has changed. Refemina’s explanation of the differences between desire, dryness and pain develops that distinction.
Her account also leaves room for a woman who is content with her experience. The purpose of discussing sexual wellbeing is not to set a required level of desire or sexual activity. It is to make questions and support available when a change is troubling or uncomfortable.
The MSD Manual defines genitourinary syndrome of menopause as a range of genital and sexual symptoms that can also include urinary symptoms. These are associated with reduced estrogen and other sex steroids. The description includes dryness and irritation alongside reduced lubrication and discomfort during sex.
The manual describes assessment as including a medical history and pelvic examination. That places the symptoms within a clinical evaluation rather than making a symptom list a basis for self-diagnosis. For an individual woman, a qualified clinician can assess the concern and discuss which options fit her circumstances.
The reference also distinguishes two approaches that are sometimes grouped together in everyday conversation. Lubricants reduce friction during sexual activity. Vaginal moisturizers are used regularly to relieve dryness. The manual describes these as options for mild symptoms and notes that ingredients such as fragrances or alcohol may worsen irritation.
For persistent or more significant symptoms, the MSD Manual describes prescription approaches. Their presence in clinical guidance is a reason to ask about options rather than assume discomfort must simply be endured. Choosing an approach remains a personal clinical decision. These treatments should not be presented as a universal answer to every question about desire or intimacy.
The Grove Medical Group’s NHS explainer includes poor sleep and mood changes alongside vaginal dryness and discomfort during sex. Its account supports a conversation that makes room for several concerns rather than reducing the appointment to one symptom.
Beresford likewise discusses comfort and libido alongside sleep and mood. The practical value is in naming what has changed and what is affecting wellbeing. A woman does not need to arrive with a settled explanation before raising the subject.
This is where a whole-person approach has value without becoming vague. The starting point can remain concrete: discomfort during sex or a change in sexual interest. Other changes can then be brought into the discussion where they are relevant. Refemina’s guide to putting low desire into a broader assessment offers a related framework.
The DESIblitz article offers this sample wording for an appointment:
> “I’m going through changes in my sexual desire and/or comfort, and I’d like to understand whether perimenopause could be contributing and what my options are.”
This is a suggested patient opener rather than a diagnostic statement. It names the concern and asks about a possible contributor without claiming to know the cause. The useful part is its directness: a woman can ask a healthcare question without offering a public account of her intimate life.
Beresford also suggests starting small when speaking with a partner. That does not make a partner conversation a prerequisite for seeking clinical support. In the interview’s framing, either conversation can begin with the particular concern rather than an explanation of everything that has changed.
For someone who wants to preserve privacy, the distinction is practical. Seeking help does not require adopting a new identity as an outspoken person or becoming comfortable with every kind of sexual conversation. It can begin with one specific question in the setting where an answer is needed.
The useful direction for practice is to make sexual-health questions easier to raise while preserving privacy and assessing the concern a woman actually brings.
Sexual privacy becomes a different concern when unanswered questions about comfort or desire are left behind it. Refemina’s research-led writing addresses overlooked or sensationalised questions about intimacy, giving women clearer context for sexual wellbeing and confidence without presenting hormones or supplements as a single answer to the wider experience of midlife.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources